ArticleZeitschrift fur Rheumatologie2018

[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].

F Proft et al.PubMed ↗Publisher ↗

No numbers read from the abstract.